Omnimmune Net Income From Continuing Ops from 2010 to 2026
| OMMH Stock | USD 0.0001 0.00 0.00% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -1.6 M | Current Value -1.7 M | Quarterly Volatility 414.2 K |
Check Omnimmune Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omnimmune Holdings' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Omnimmune financial statements analysis is a perfect complement when working with Omnimmune Holdings Valuation or Volatility modules.
Omnimmune | Net Income From Continuing Ops | Build AI portfolio with Omnimmune Stock |
The Net Income From Continuing Ops trend for Omnimmune Holdings offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Omnimmune Holdings is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Omnimmune Holdings' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Omnimmune Holdings over the last few years. It is Omnimmune Holdings' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omnimmune Holdings' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Omnimmune Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (1,644,406) | |
| Coefficient Of Variation | (25.19) | |
| Mean Deviation | 194,831 | |
| Median | (1,761,268) | |
| Standard Deviation | 414,191 | |
| Sample Variance | 171.6B | |
| Range | 1.7M | |
| R-Value | (0.35) | |
| Mean Square Error | 160.6B | |
| R-Squared | 0.12 | |
| Significance | 0.17 | |
| Slope | (28,680) | |
| Total Sum of Squares | 2.7T |
Omnimmune Net Income From Continuing Ops History
About Omnimmune Holdings Financial Statements
Investors use fundamental indicators, such as Omnimmune Holdings' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Omnimmune Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Loss | -1.6 M | -1.7 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Omnimmune Holdings Correlation against competitors. For more detail on how to invest in Omnimmune Stock please use our How to Invest in Omnimmune Holdings guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is there potential for Biotechnology market expansion? Will Omnimmune introduce new products? Factors like these will boost the valuation of Omnimmune Holdings. Anticipated expansion of Omnimmune directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Omnimmune Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Omnimmune Holdings's market price often diverges from its book value, the accounting figure shown on Omnimmune's balance sheet. Smart investors calculate Omnimmune Holdings' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Omnimmune Holdings' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Omnimmune Holdings' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Omnimmune Holdings should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Omnimmune Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.